FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns a method for identifying the patients suffering myocardial infarction and a high risk of a cardiac pathology, involving a post-infarction examination of patient's biological fluids to measure vascular endothelium growth factor B (VEGFB), thrombospondin-1 (THBS1) and placental growth factor (PGF) levels. Besides, the group of inventions concerns a method for prediction for the patients suffering myocardial infarction; a system for identifying the suffering myocardial infarction.
EFFECT: group of inventions provides the reliable diagnosing of the high risk of the post-infarction cardiac pathology in the patients.
18 cl, 2 ex, 9 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF HEART FAILURE IN HUMANS | 2020 |
|
RU2811365C2 |
| METHOD FOR ASSESSING THE PROBABILITY OF DEVELOPING UNFAVORABLE HEART LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION | 2021 |
|
RU2770285C1 |
| METHOD FOR DIAGNOSING THE DEVELOPMENT OF ISCHEMIC CARDIOMYOPATHY IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2021 |
|
RU2765598C1 |
| TRANSLATIONAL MODEL OF CHRONIC HEART FAILURE: THE METHOD AND CRITERIA OF FORMATION ASSESSMENT | 2018 |
|
RU2744681C1 |
| METHODS FOR IDENTIFYING AND PREDICTING RISK OF CARDIOVASCULAR EVENT OR DISEASE OR FATAL OUTCOME, METHODS FOR ASSESSING SEVERITY AND MONITORING OF CARDIOVASCULAR EVENT OR DISEASE, METHOD FOR MONITORING EFFECTIVENESS OF THERAPY | 2014 |
|
RU2721690C2 |
| MIDREGIONAL PRO-ATRIAL NATRIURETIC PEPTIDE (pro-ANP) PRECURSOR APPLICABLE FOR IDENTIFYING PATIENTS WITH ATRIAL FIBRILLATION STARTED LESS THAN 48 HOURS EARLIER | 2012 |
|
RU2570755C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE DECOMPENSATION OF ISCHEMIC CHRONIC HEART FAILURE WITH SYSTOLIC DYSFUNCTION OF THE LEFT VENTRICLE OF THE HEART AFTER COMPLETE MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770271C1 |
| PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE | 2013 |
|
RU2672561C2 |
| ADRENOMEDULLINE FOR ASSESSING CONGESTION IN INDIVIDUAL WITH ACUTE HEART FAILURE | 2022 |
|
RU2835424C2 |
| METHOD FOR PREDICTING RISK OF GETTING CARDIOVASCULAR EVENT IN FEMALE SUBJECT | 2013 |
|
RU2652304C2 |
